<DOC>
	<DOCNO>NCT00123071</DOCNO>
	<brief_summary>This observational study provide data ( variation ventricular size function ) essential design conduct clinical trial . In addition , study evaluate intra- inter-study variability see echocardiography .</brief_summary>
	<brief_title>Variability Ventricular Mass , Volume , &amp; Ejection Fraction Pediatric Cardiomyopathy Patients-Pediatric Heart Network</brief_title>
	<detailed_description>BACKGROUND : Cardiomyopathy important cause chronic disability death pediatric patient currently account approximately 50 % cardiac transplant perform childhood . Left ventricular ( LV ) size function important independent predictor outcome , echocardiography primary way ass ventricular function child . Although extensive experience technology , data limit ventricular function change time child , major impediment conduct controlled trial therapy child . This study approve Institutional Review Boards/Research Ethics Boards participate clinical center : Hospital Sick Children , Toronto , Canada Children 's Hospital Boston , Boston , MA Columbia College Physicians Surgeons , New York , NY Children 's Hospital Philadelphia , Philadelphia , PA Duke University Medical Center , Durham , NC Brody School Medicine East Carolina University , Greenville , NC Wake Forest Baptist Medical Center , Winston Salem , NC Medical University South Carolina , Charleston , SC Primary Children 's Medical Center , Salt Lake City , UT Washington University , St. Louis , MO DESIGN NARRATIVE : This observational study prospectively evaluate pediatric patient dilate cardiomyopathy undergo clinically indicate echocardiographic evaluation LV function . Patients undergo least two echocardiogram 3 18 month apart study perform ultrasonographer . All study send core laboratory evaluation variability LV mass , volume , ejection fraction .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Less 22 year age Any race Diagnosis dilate cardiomyopathy LV diastolic diameter great 5.5 cm ( zscore BSA great 2 ) primary image acquisition first study echocardiogram LV ejection fraction le 50 % ( zscore age le 2 ) shorten fraction le 28 % ( zscore age le 2 ) measure primary image acquisition first study echocardiogram Disease onset great 2 month prior screen Anticipated undergo repeat evaluation institution least 3 month 13 month later Informed consent parent ( ) legal guardian assent subject require Hypertrophic cardiomyopathy Restrictive cardiomyopathy Myocardial noncompaction ( LV hypertrabeculation ) ; patient eligible study long echocardiogram perform time screen evidence myocardial noncompaction Ventricular pace rhythm Atrial ventricular ectopy ratio great 1:4 Suspected acute myocarditis Tachycardiainduced cardiomyopathy Congenital heart disease ( repair unrepaired ) Currently intravenous inotropic support Current leave ventricular assist device ( LVAD ) extracorporeal membrane oxygenation ( ECMO ) Heart transplant wait list status 1A 1B Comorbid condition precludes ability successfully obtain echocardiogram accord specification study protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>